| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protokinetix, Inc. (PKTX) has 0 insiders with recent SEC Form 4 filings, including 23 buys and 0 sells. PKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 25, 2018 | Smith Clarence Edward | President &CEO | Buy | 228,100 | $0.06 | $12,634.80 | +0.9% | |
| May 22, 2018 | Smith Clarence Edward | President &CEO | Buy | 434,047 | $0.05 | $20,091.97 | +2.4% | |
| May 18, 2018 | Guzzetta Michael Richard | CFO | Buy | 31,500 | $0.04 | $1,260.00 | New | |
| Jan 12, 2018 | Smith Clarence Edward | President &CEO | Buy | 2,359,240 | $0.05 | $117,962.00 | New | |
| Feb 6, 2017 | Woodward Susan Marie | CFO | Buy | 250,000 | $0.04 | $10,000.00 | New | |
| Feb 6, 2017 | Smith Clarence Edward | President &CEO | Buy | 750,000 | $0.04 | $30,000.00 | +1.4% | |
| Dec 20, 2016 | Smith Clarence Edward | President &CEO | Buy | 4,000,000 | $0.04 | $160,000.00 | +8.2% | |
| Nov 30, 2016 | Smith Clarence Edward | President &CEO | Buy | 3,500,000 | $0.04 | $140,000.00 | +7.7% | |
| Nov 4, 2016 | Smith Clarence Edward | President &CEO | Buy | 1,250,000 | $0.04 | $50,000.00 | +2.8% | |
| Sep 29, 2016 | Smith Clarence Edward | President &CEO | Buy | 500,000 | $0.04 | $20,000.00 | +1.1% |